Study of Quality of Life in Freeman-Sheldon Syndrome and Related Conditions
Launched by FREEMAN-SHELDON RESEARCH GROUP, INC. · Mar 1, 2011
Trial Information
Current as of June 02, 2025
Terminated
Keywords
ClinConnect Summary
This study is a research project initiated by the graduate research student (Mikaela I. Poling) and assisted by the clinical genetics fellow and graduate student (Andrés Morales) in partial fulfilment the requirements for their Masters degrees in Clinical and Applied Physiology, under approval, direction, and supervision of the study PI (Rodger J. McCormick).
Mental Health and Congenital Deformities:
Apajasalo et al. (1998) found significantly decreased health-related quality of life versus controls among adults and youth ages with chondrodysplasias. Differences in adult scores were in th...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Freeman-Sheldon syndrome,
- • Sheldon-Hall syndrome,
- • Distal arthrogryposis type 1, or
- • distal arthrogryposis type 3
- • Deceased probands with enough clinical information available to satisfy study requirements
- • Probands who participated in a prior Freeman-Sheldon Research Group (FSRG)-study are automatically accepted, since their diagnoses have been confirmed by FSRG clinical faculty.
- • Probands with a reported qualifying diagnosis, who have not participated in a prior FSRG-study, will be required to complete the complete a survey from a prior study and provide photographs and any requested medical records to confirm their diagnoses.
- • Family members and other close contacts may enrol, so long as they have either resided with or had substantial and prolonged contact with a proband, who has an FSRG-verified qualifying diagnosis. Investigators will make the final decision on a case-by-case basis, based on information provided.
- Exclusion Criteria:
- • Patients with other anomalies, not having one of the above syndromes, will not be accepted.
- • Deceased probands will not be accepted for analysis, without enough clinical data available to satisfy study data collection requirements.
- • Patients or parents of minor children not willing to give consent will not be included.
- • Family members or other contacts that neither resided with nor had substantial and prolonged contact with the proband.
About Freeman Sheldon Research Group, Inc.
Freeman-Sheldon Research Group, Inc. is a pioneering clinical research organization dedicated to advancing the understanding and treatment of rare genetic disorders, particularly Freeman-Sheldon syndrome. With a commitment to innovative research and patient-centric approaches, the organization collaborates with healthcare professionals, researchers, and patient communities to conduct rigorous clinical trials. By leveraging cutting-edge methodologies and a multidisciplinary team, Freeman-Sheldon Research Group aims to develop effective therapies and improve the quality of life for individuals affected by these conditions, fostering hope and progress in the field of genetic medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Buckhannon, West Virginia, United States
Guatemala City, , Guatemala
Patients applied
Trial Officials
Robert L Chamberlain, MD
Principal Investigator
Freeman-Sheldon Research Group, Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials